MedPath

R9 - LIQ

R9 - LIQ

Discontinued
DIN Number

02116758

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

dr reckeweg canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02116758
AIG Number0926488002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (9)

BELLADONNAActive
Strength: 4 D / ML
Monograph: BELLADONNA
BRYONIAActive
Strength: 3 D / ML
Monograph: BRYONIA
COCHINEALActive
Strength: 6 D / ML
Monograph: COCHINEAL
CORALLIUM RUBRUMActive
Strength: 12 D / ML
Monograph: CORALLIUM RUBRUM
CUPRIC ACETATEActive
Strength: 12 D / ML
Monograph: CUPRIC ACETATE
DROSERA ROTUNDIFOLIAActive
Strength: 4 D / ML
Monograph: DROSERA ROTUNDIFOLIA
IPECACActive
Strength: 6 D / ML
Monograph: IPECAC
SPONGIA TOSTAActive
Strength: 6 D / ML
Monograph: SPONGIA TOSTA
STICTA PULMONARIAActive
Strength: 4 D / ML
Monograph: STICTA PULMONARIA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.